Why Dissolution Testing Matters for Supplement Brands

At SREKE, we understand that dissolution testing is not just a regulatory checkbox—it is a critical quality attribute that directly impacts product performance and consumer trust. For supplement brands, the bioavailability of active ingredients depends on how effectively a tablet or capsule releases its contents in the gastrointestinal tract. Our GMP-certified facility in Guangzhou integrates dissolution testing into our quality assurance protocols to ensure every batch meets rigorous release criteria.

Dissolution testing measures the rate and extent to which an active pharmaceutical ingredient (API) or botanical extract is released from its dosage form under controlled conditions. According to USP General Chapter <711> Dissolution, this test helps verify product consistency, supports formulation development, and ensures compliance with pharmacopeial standards. For dietary supplements, while USP monographs may not always specify dissolution requirements, we follow USP <711> as a best-practice benchmark and align with FDA guidance on quality systems for dietary supplements (21 CFR Part 111).

Without reliable dissolution data, brands risk product failure, regulatory observations, or consumer dissatisfaction due to inconsistent potency. Our team uses calibrated dissolution apparatuses (Apparatus 1–4 per USP) and validates methods to match in vivo performance, giving you confidence that your product delivers as promised.

Key Manufacturing Considerations at SREKE

At SREKE, we approach dissolution testing as an integral part of our OEM/ODM manufacturing process. Our facility adheres to ISO 22000, HACCP, and GMP standards, ensuring that dissolution testing is conducted under validated conditions with proper documentation. Here are the key considerations we address for tablet and capsule products:

• Formulation design: We evaluate excipient selection, binder systems, and compression parameters to optimize disintegration and dissolution. For hard gelatin capsules, we consider shell composition and fill characteristics that affect release profiles.
• Method validation: Our quality control lab validates dissolution methods for specificity, accuracy, precision, and linearity, following ICH Q2(R1) guidelines where applicable.
• Batch release testing: Each production batch undergoes dissolution testing against predefined acceptance criteria. We use media such as simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) to mimic physiological conditions.
• Stability-indicating methods: We develop dissolution methods that can detect changes over shelf life, supporting stability studies per ICH Q1A(R2) guidelines.
• Regulatory compliance: Our testing protocols align with FDA dietary supplement GMPs (21 CFR 111.75) and EFSA requirements for novel foods and health claims, ensuring your product meets market-specific standards.

How SREKE Helps You Get to Market Faster

At SREKE, we streamline the path from formulation to finished product by integrating dissolution testing early in the development process. Our experienced team of formulators and quality engineers works collaboratively to reduce iteration cycles and accelerate time-to-market. Here's how we support your launch:

• Low MOQ flexibility: We offer competitive minimum order quantities for tablets and capsules, allowing brands to test the market with smaller runs before scaling production.
• Accelerated lead times: Our streamlined manufacturing workflow, supported by real-time dissolution monitoring, reduces development timelines by up to 30% compared to traditional OEM processes.
• End-to-end compliance: We handle documentation for FDA registration, EFSA notifications, and other regulatory filings, ensuring your product is market-ready in target regions.
• Packaging and labeling support: Our in-house packaging team ensures that your product's labeling complies with FDA dietary supplement labeling guidelines and EFSA health claim regulations.
• Dedicated account management: Each client is assigned a project manager who coordinates formulation, testing, and production schedules, providing transparent updates on progress and dissolution results.

Industry Trends and Market Opportunities

The dietary supplement industry is evolving rapidly, with consumers demanding higher bioavailability and faster-acting products. At SREKE, we track market trends and leverage dissolution testing insights to help brands capitalize on emerging opportunities:

• Fast-dissolving tablets: There is growing demand for orally disintegrating tablets (ODTs) and fast-dissolving formulations, especially for vitamins and minerals. Our R&D team can develop ODTs with dissolution profiles under 30 seconds, enhancing consumer convenience.
• Plant-based and vegan capsules: As consumer preferences shift toward plant-based options, we offer hydroxypropyl methylcellulose (HPMC) capsules that meet dissolution requirements while aligning with vegan and clean-label trends.
• Personalized nutrition: Custom-dosed tablets and capsules are gaining traction in the personalized supplement space. Our flexible manufacturing lines support small-batch production with rigorous dissolution testing for each unique formula.
• Global compliance: With increasing scrutiny from FDA and EFSA, brands that proactively address dissolution variability through robust testing are better positioned to avoid regulatory warnings and maintain market access.

Frequently Asked Questions

What is the typical dissolution testing timeline at SREKE?

At SREKE, dissolution testing for routine batch release typically takes 3–5 business days after sample receipt. For method development and validation, we allocate 2–4 weeks depending on formulation complexity. Our team provides detailed dissolution reports with USP-compliant data for regulatory submissions.

Do you test dissolution for both tablets and capsules?

Yes, our GMP-certified facility performs dissolution testing on tablets, hard gelatin capsules, and HPMC capsules. We use USP Apparatus 1 (basket) and Apparatus 2 (paddle) as standard, with method customization based on product characteristics and target market requirements.

How does dissolution testing impact my product's shelf life?

Dissolution testing is a key component of stability studies. At SREKE, we conduct accelerated and long-term stability testing per ICH guidelines, monitoring dissolution changes over time to establish expiration dates and storage conditions that ensure product potency throughout shelf life.

Can you help with regulatory filings related to dissolution?

Absolutely. Our compliance team assists with FDA dietary supplement facility registration, EFSA novel food notifications, and other regulatory submissions. We provide dissolution data packages that meet agency expectations, reducing the risk of observations or delays.

What are the MOQ and lead time for OEM tablet or capsule production?

Our MOQ for tablets and capsules starts at 10,000 units per SKU, with lead times of 6–8 weeks from formula approval to shipment. We offer expedited schedules for urgent launches, subject to formulation complexity and raw material availability. Contact our team for a detailed quote.

Ready to launch your supplement brand? SREKE provides GMP-certified OEM/ODM manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us for a free quote or email [email protected] — we respond within 24 hours.